Hiroshi Katayama Selected Research

S-1 plus cisplatin

3/2021	Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
11/2019	An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis.
1/2019	Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).
11/2015	A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Katayama Research Topics

Disease

32	Neoplasms (Cancer) 05/2024 - 12/2003
24	Stomach Neoplasms (Stomach Cancer) 11/2023 - 01/2009
9	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2008
7	Lymphatic Metastasis 01/2022 - 06/2012
7	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 09/2014
6	Adenocarcinoma 01/2022 - 02/2014
6	Esophageal Neoplasms (Esophageal Cancer) 12/2017 - 04/2007
6	Chromosomal Instability (Chromosome Stability) 01/2016 - 09/2002
5	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2004
5	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2017
5	Infections 01/2021 - 05/2004
5	Carcinogenesis 01/2020 - 09/2002
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023 - 10/2018
4	Esophageal Squamous Cell Carcinoma 12/2021 - 01/2016
4	Inflammation (Inflammations) 10/2021 - 11/2005
4	Carcinoma (Carcinomatosis) 04/2014 - 04/2007
4	Hemorrhagic Shock 07/2010 - 02/2008
3	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 07/2018
3	Neutropenia 12/2021 - 03/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 09/2007
3	Lung Neoplasms (Lung Cancer) 09/2020 - 09/2007
3	Genomic Instability 01/2016 - 01/2008
2	Disease Progression 05/2024 - 02/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2023 - 01/2015
2	Hypoxia (Hypoxemia) 11/2021 - 03/2009
2	Cardiac Arrhythmias (Arrythmia) 11/2021 - 09/2002
2	Residual Neoplasm 01/2021 - 07/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 03/2010
2	Linitis Plastica 11/2019 - 01/2019
2	Leukopenia 01/2019 - 03/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 04/2014
2	Hyponatremia 01/2018 - 03/2017
2	Asthma (Bronchial Asthma) 01/2018 - 06/2017
2	Pneumonia (Pneumonitis) 01/2017 - 07/2010
2	Pathologic Constriction (Stenosis) 04/2015 - 05/2006
2	Critical Illness (Critically Ill) 03/2010 - 01/2006
2	Hyperglycemia 03/2010 - 04/2007
2	Abdominal Aortic Aneurysm 06/2009 - 06/2009
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2008 - 01/2004
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2008 - 04/2002
2	Wounds and Injuries (Trauma) 10/2006 - 08/2004

Drug/Important Bio-Agent (IBA)

12	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 06/2012
11	Aurora Kinase AIBA 03/2024 - 01/2004
9	Fluorouracil (Carac)FDA LinkGeneric 08/2023 - 01/2015
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 01/2017
6	Leucovorin (Folinic Acid)FDA Link 01/2023 - 01/2017
6	Docetaxel (Taxotere)FDA Link 02/2020 - 06/2012
5	Gemcitabine FDA Link 07/2023 - 04/2016
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 04/2014
5	Phosphotransferases (Kinase)IBA 04/2011 - 12/2003
4	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2008
4	S-1 plus cisplatinIBA 03/2021 - 11/2015
4	Aurora KinasesIBA 01/2016 - 12/2003
4	Heme Oxygenase-1IBA 01/2009 - 08/2004
3	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2020
3	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 07/2018
3	Interleukin-17 (Interleukin 17)IBA 10/2021 - 06/2017
3	Codon (Codons)IBA 11/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 12/2016 - 01/2016
3	Estrogen ReceptorsIBA 04/2011 - 09/2007
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2011 - 09/2009
3	Angiotensin IIIBA 06/2009 - 07/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 02/2004
2	folfirinoxIBA 01/2023 - 10/2018
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 10/2018
2	Ethanol (Ethyl Alcohol)IBA 11/2020 - 01/2016
2	AntibodiesIBA 01/2020 - 10/2018
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 03/2009
2	leucylarginineIBA 02/2017 - 01/2016
2	Trastuzumab (Herceptin)FDA Link 11/2015 - 02/2014
2	Estrogens (Estrogen)FDA Link 04/2011 - 02/2010
2	Peroxidase (Myeloperoxidase)IBA 07/2010 - 01/2009
2	Interleukin-10 (Interleukin 10)IBA 07/2010 - 01/2009
2	Carbon MonoxideIBA 07/2010 - 01/2006
2	Messenger RNA (mRNA)IBA 07/2010 - 02/2004
2	AndrogensIBA 03/2010 - 01/2008
2	Insulin (Novolin)FDA Link 03/2010 - 09/2002
2	isomaltulose (palatinose)IBA 03/2010 - 04/2007
2	EnzymesIBA 06/2009 - 10/2006
2	Chymases (Chymase)IBA 06/2009 - 07/2006
2	LipopolysaccharidesIBA 02/2009 - 02/2004
2	Caspase 3 (Caspase-3)IBA 01/2009 - 02/2008
2	Heme (Haem)IBA 10/2006 - 01/2006
2	oprelvekin (Neumega)FDA Link 10/2006 - 02/2004
2	Interleukin-11 (Interleukin 11)IBA 10/2006 - 02/2004

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 09/2023 - 06/2012
18	Therapeutics 09/2020 - 04/2002
15	Gastrectomy 11/2023 - 01/2009
9	Adjuvant Chemotherapy 11/2023 - 04/2014
9	Chemoradiotherapy 08/2023 - 12/2015
8	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2009
8	Esophagectomy 12/2015 - 11/2005
5	Radiotherapy 07/2023 - 04/2016
4	Neoadjuvant Therapy 03/2021 - 01/2015
4	Ligation 09/2014 - 09/2002
2	Induction Chemotherapy 07/2023 - 02/2021
2	Colectomy 01/2022 - 09/2014
2	Segmental Mastectomy (Lumpectomy) 09/2020 - 05/2017
2	General Anesthesia 08/2010 - 01/2006
2	Catheters 10/2007 - 04/2003